Design, rationale, and baseline characteristics of a pilot randomized clinical trial of nicotine treatment for pulmonary sarcoidosis

INTRODUCTION: Sarcoidosis is a systemic granulomatous disease of unknown cause afflicting young to middle-aged adults. The majority of patients with active pulmonary sarcoidosis complain of overwhelming fatigue, which often persists despite administration of immune-modulating drugs typically used to...

Descripción completa

Detalles Bibliográficos
Autores principales: Hade, Erinn M., Smith, Rachel M., Culver, Daniel A., Crouser, Elliott D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7567036/
https://www.ncbi.nlm.nih.gov/pubmed/33089005
http://dx.doi.org/10.1016/j.conctc.2020.100669

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7567036/
https://www.ncbi.nlm.nih.gov/pubmed/33089005
http://dx.doi.org/10.1016/j.conctc.2020.100669

Ejemplares similares